MENU
ACXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Acurx Pharmaceuticals (ACXP) Ownership - Who owns Acurx Pharmaceuticals?
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration... Show more
Profile
Industry
N/A
Address
259 Liberty Avenue
Phone
+1 917 533-1469
Employees
4
Web
https://www.acurxpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.6M
P/E Ratio
N/A
Total Cash
5.76M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-1.92
Dividend Yield
N/A
Total Cash/Share
0.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ACXP
Capitalization
8.6M
P/E Ratio
N/A
Risk (Beta)
-1.92
Dividend Yield
N/A
Total Cash
5.76M
Total Cash/Share
0.30
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.66M
P/B Ratio
3.23
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16.8K
Current Ratio
1.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-250.15
Shares Held By Institutions
2.08M
Shares Outstanding - Current
19.5M
Total Liabilities
3.32M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.705
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
259 Liberty Avenue
Phone
+1 917 533-1469
Employees
4
Web
https://www.acurxpharma.com